- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 21 - Expectations for Newly Developing Agents
During this segment, the panelists explore newer therapeutic agents that are now receiving a lot of attention in the healthcare market for the management of cardiovascular health, and discuss which products have the greatest potential when treating cardiometabolic events.
David Calabrese, RPh, MHP, discusses the large number of late-phase agents that are available to treat diabetes and believes that product variety allows clinicians to tailor treatment specifically to the patient.
Additionally, Kenneth L. Schaecher, MD, FACP, CPC, discusses the potential of vaccine therapy and gene therapy, which are currently being studied for the treatment of type 1 diabetes.
Yehuda Handelsman, MD, FACP, FACE, FNLA, concludes the discussion by summarizing the most promising products available to treat other cardiometabolic events such as lipid disorders and obesity.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
